Cargando…
Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland
OBJECTIVE: To estimate the cost-effectiveness of using an extensively hydrolyzed casein formula (eHCF) containing the probiotic Lactobacillus rhamnosus GG (eHCF + LGG; Nutramigen LGG) as an initial treatment for cow’s milk allergy compared with eHCF alone and amino acid formulas (AAF) in Poland from...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934487/ https://www.ncbi.nlm.nih.gov/pubmed/27418845 http://dx.doi.org/10.2147/CEOR.S105748 |
_version_ | 1782441342972985344 |
---|---|
author | Guest, Julian F Weidlich, Diana Kaczmarski, Maciej Jarocka-Cyrta, Elzbieta Kobelska-Dubiel, Natalia Krauze, Agnieszka Sakowska-Maliszewska, Iwona Zawadzka-Krajewska, Anna |
author_facet | Guest, Julian F Weidlich, Diana Kaczmarski, Maciej Jarocka-Cyrta, Elzbieta Kobelska-Dubiel, Natalia Krauze, Agnieszka Sakowska-Maliszewska, Iwona Zawadzka-Krajewska, Anna |
author_sort | Guest, Julian F |
collection | PubMed |
description | OBJECTIVE: To estimate the cost-effectiveness of using an extensively hydrolyzed casein formula (eHCF) containing the probiotic Lactobacillus rhamnosus GG (eHCF + LGG; Nutramigen LGG) as an initial treatment for cow’s milk allergy compared with eHCF alone and amino acid formulas (AAF) in Poland from the perspective of the Polish National Health Fund (Narodowy Fundusz Zdrowia [NFZ]) and parents. METHODS: Decision modeling was used to estimate the probability of cow’s milk allergic infants developing tolerance to cow’s milk by 18 months. The model also estimated the cost to the NFZ and parents (Polish Zloty [PLN] at 2013–2014 prices) for managing infants over 18 months after starting one of the formulas as well as the relative cost-effectiveness of each of the formulas. RESULTS: The probability of developing tolerance to cow’s milk by 18 months was higher among infants who were fed eHCF + LGG (0.82) compared with those fed eHCF alone (0.53) or an AAF (0.22). An infant who is initially managed with eHCF + LGG is expected to consume fewer health care resources than infants managed with the other formulas. Hence, the estimated total health care cost incurred by the NFZ for initially feeding infants with eHCF + LGG (PLN 5,693) was less than that of feeding infants with eHCF alone (PLN 7,749) or an AAF (PLN 24,333). However, the total cost incurred by parents for initially feeding infants with an AAF (PLN 815) was marginally less than that of feeding with eHCF + LGG (PLN 993), which was less than that of feeding with eHCF alone (PLN 1,226). CONCLUSION: Using eHCF + LGG instead of eHCF alone or an AAF for first-line management of newly diagnosed infants with cow’s milk allergy affords a cost-effective use of NFZ-funded resources, since it improves outcome for less cost. Whether eHCF + LGG would be viewed as being cost-effective by parents is dependent on their willingness to pay an additional cost for additional tolerance acquisition to cow’s milk. |
format | Online Article Text |
id | pubmed-4934487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-49344872016-07-14 Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland Guest, Julian F Weidlich, Diana Kaczmarski, Maciej Jarocka-Cyrta, Elzbieta Kobelska-Dubiel, Natalia Krauze, Agnieszka Sakowska-Maliszewska, Iwona Zawadzka-Krajewska, Anna Clinicoecon Outcomes Res Original Research OBJECTIVE: To estimate the cost-effectiveness of using an extensively hydrolyzed casein formula (eHCF) containing the probiotic Lactobacillus rhamnosus GG (eHCF + LGG; Nutramigen LGG) as an initial treatment for cow’s milk allergy compared with eHCF alone and amino acid formulas (AAF) in Poland from the perspective of the Polish National Health Fund (Narodowy Fundusz Zdrowia [NFZ]) and parents. METHODS: Decision modeling was used to estimate the probability of cow’s milk allergic infants developing tolerance to cow’s milk by 18 months. The model also estimated the cost to the NFZ and parents (Polish Zloty [PLN] at 2013–2014 prices) for managing infants over 18 months after starting one of the formulas as well as the relative cost-effectiveness of each of the formulas. RESULTS: The probability of developing tolerance to cow’s milk by 18 months was higher among infants who were fed eHCF + LGG (0.82) compared with those fed eHCF alone (0.53) or an AAF (0.22). An infant who is initially managed with eHCF + LGG is expected to consume fewer health care resources than infants managed with the other formulas. Hence, the estimated total health care cost incurred by the NFZ for initially feeding infants with eHCF + LGG (PLN 5,693) was less than that of feeding infants with eHCF alone (PLN 7,749) or an AAF (PLN 24,333). However, the total cost incurred by parents for initially feeding infants with an AAF (PLN 815) was marginally less than that of feeding with eHCF + LGG (PLN 993), which was less than that of feeding with eHCF alone (PLN 1,226). CONCLUSION: Using eHCF + LGG instead of eHCF alone or an AAF for first-line management of newly diagnosed infants with cow’s milk allergy affords a cost-effective use of NFZ-funded resources, since it improves outcome for less cost. Whether eHCF + LGG would be viewed as being cost-effective by parents is dependent on their willingness to pay an additional cost for additional tolerance acquisition to cow’s milk. Dove Medical Press 2016-06-28 /pmc/articles/PMC4934487/ /pubmed/27418845 http://dx.doi.org/10.2147/CEOR.S105748 Text en © 2016 Guest et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Guest, Julian F Weidlich, Diana Kaczmarski, Maciej Jarocka-Cyrta, Elzbieta Kobelska-Dubiel, Natalia Krauze, Agnieszka Sakowska-Maliszewska, Iwona Zawadzka-Krajewska, Anna Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland |
title | Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland |
title_full | Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland |
title_fullStr | Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland |
title_full_unstemmed | Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland |
title_short | Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland |
title_sort | relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic lactobacillus rhamnosus gg in managing infants with cow’s milk allergy in poland |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934487/ https://www.ncbi.nlm.nih.gov/pubmed/27418845 http://dx.doi.org/10.2147/CEOR.S105748 |
work_keys_str_mv | AT guestjulianf relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland AT weidlichdiana relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland AT kaczmarskimaciej relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland AT jarockacyrtaelzbieta relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland AT kobelskadubielnatalia relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland AT krauzeagnieszka relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland AT sakowskamaliszewskaiwona relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland AT zawadzkakrajewskaanna relativecosteffectivenessofusinganextensivelyhydrolyzedcaseinformulacontainingtheprobioticlactobacillusrhamnosusgginmanaginginfantswithcowsmilkallergyinpoland |